Product logins

Find logins to all Clarivate products below.


Aortic Repair Devices | Market Insights | Asia Pacific | 2021

Following the initial impact of the COVID-19 pandemic, the Asia Pacific market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent grafts. However, endovascular procedure volume growth will be hindered to some extent by lack of physicians trained in endovascular techniques, limited awareness and screening of aneurysms, and limited availability of modern health care facilities among some of the countries covered.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Aortic Repair Devices in Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…